Translational perspectives on perfusion-diffusion mismatch in ischemic stroke

International Journal of Stroke

Volumn 10, Issue 2, 2015, Pages 153-162

  Campbell, Bruce C V ^a   Macrae, I Mhairi ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Diffusion imaging; MRI; Penumbra; Perfusion imaging; Stroke; Thrombolytic therapy

Indexed keywords

BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN SCINTISCANNING; COLLATERAL CIRCULATION; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; FIBRINOLYTIC THERAPY; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; NONHUMAN; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; REPERFUSION; REVIEW; ANIMAL; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; STROKE;

ANIMALS; BRAIN ISCHEMIA; HUMANS; MAGNETIC RESONANCE IMAGING; STROKE;

EID: 84921608896     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12186     Document Type: Review

References (77)

1. Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 1981; 12:723-725.
2. Shuaib A, Butcher K, Mohammad AA, Saqqur M, Liebeskind DS. Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target. Lancet Neurol 2011; 10:909-921.
3. Wintermark M, Albers GW, Broderick JP etal.; for the Stroke Imaging Research (STIR) and VISTA-Imaging Investigators. Acute Stroke Imaging Research Roadmap II. Stroke 2013; doi: 10.1161/STROKEAHA.113.002015.
4. Heiss W-D. Ischemic penumbra: evidence from functional imaging in man. J Cereb Blood Flow Metab 2000; 20:1276-1293.
5. Lees KR, Bluhmki E, von Kummer R etal. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375:1695-1703.
6. Albers GW, Thijs VN, Wechsler L etal. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006; 60:508-517.
7. Davis SM, Donnan GA, Parsons MW etal. Effects of alteplase beyond 3h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008; 7:299-309.
8. Lansberg MG, Straka M, Kemp S etal. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol 2012; 11:860-867.
9. Ma H, Parsons MW, Christensen S etal. A multicentre, randomized, double blinded, placebo controlled phase 3 study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). Int J Stroke 2012; 7:74-80.
10. Schellinger PD, Thomalla G, Fiehler J etal. MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients. Stroke 2007; 38:2640-2645.
11. Hjort N, Christensen S, Sølling C etal. Ischemic injury detected by diffusion imaging 11 minutes after stroke. Ann Neurol 2005; 58:462-465.
12. Schellinger PD, Bryan RN, Caplan LR etal. Evidence-based guideline: the role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2010; 75:177-185.
13. Lansberg MG, Thijs VN, Bammer R etal. The MRA-DWI mismatch identifies patients with stroke who are likely to benefit from reperfusion. Stroke 2008; 39:2491-2496.
14. Davalos A, Blanco M, Pedraza S etal. The clinical-DWI mismatch: a new diagnostic approach to the brain tissue at risk of infarction. Neurology 2004; 62:2187-2192.
15. Lansberg MG, Thijs VN, Hamilton S etal. Evaluation of the clinical-diffusion and perfusion-diffusion mismatch models in DEFUSE. Stroke 2007; 38:1826-1830.
16. Parsons MW, Christensen S, McElduff P etal. Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab 2010; 30:1214-1225.
17. Yoo AJ, Verduzco LA, Schaefer PW etal. MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke 2009; 40:2046-2054.
18. Menezes NM, Ay H, Wang Zhu M etal. The real estate factor: quantifying the impact of infarct location on stroke severity. Stroke 2007; 38:194-197.
19. Kranz PG, Eastwood JD. Does diffusion-weighted imaging represent the ischemic core? An evidence-based systematic review. AJNR Am J Neuroradiol 2009; 30:1206-1212.
20. Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol 2007; 6:258-268.
21. Chemmanam T, Campbell BC, Christensen S etal. Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch. Neurology 2010; 75:1040-1047.
22. Sakamoto Y, Kimura K, Shibazaki K etal. Early ischaemic diffusion lesion reduction in patients treated with intravenous tissue plasminogen activator: infrequent, but significantly associated with recanalization. Int J Stroke 2013; 8:321-326.
23. Labeyrie MA, Turc G, Hess A etal. Diffusion lesion reversal after thrombolysis: a MR correlate of early neurological improvement. Stroke 2012; 43:2986-2991.
24. Campbell BCV, Purushotham A, Christensen S etal. The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. J Cereb Blood Flow Metab 2012; 32:50-56.
25. Li F, Liu KF, Silva MD etal. Transient and permanent resolution of ischemic lesions on diffusion-weighted imaging after brief periods of focal ischemia in rats: correlation with histopathology. Stroke 2000; 31:946-954.
26. Guadagno JV, Jones PS, Aigbirhio FI etal. Selective neuronal loss in rescued penumbra relates to initial hypoperfusion. Brain 2008; 131:2666-2678.
27. Tourdias T, Dousset V, Sibon I etal. Magnetization transfer imaging shows tissue abnormalities in the reversible penumbra. Stroke 2007; 38:3165-3171.
28. Purushotham A, Campbell BC, Straka M etal. Apparent diffusion coefficient threshold for delineation of ischemic core. Int J Stroke 2013, doi: 10.1111/ijs.12068.
29. An H, Ford AL, Vo K, Powers WJ, Lee JM, Lin W. Signal evolution and infarction risk for apparent diffusion coefficient lesions in acute ischemic stroke are both time- and perfusion-dependent. Stroke 2011; 42:1276-1281.
30. Straka M, Albers GW, Bammer R. Real-time diffusion-perfusion mismatch analysis in acute stroke. J Magn Reson Imaging 2010; 32:1024-1037.
31. Butcher K, Parsons M, Allport L etal. Rapid assessment of perfusion-diffusion mismatch. Stroke 2008; 39:75-81.
32. Jones TH, Morawetz RB, Crowell RM etal. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 1981; 54:773-782.
33. Marchal G, Beaudouin V, Rioux P etal. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. Stroke 1996; 27:599-606.
34. Hakim AM, Evans AC, Berger L etal. The effect of nimodipine on the evolution of human cerebral infarction studied by PET. J Cereb Blood Flow Metab 1989; 9:523-534.
35. Baron JC. Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis 2001; 11(Suppl. 1):2-8.
36. Christensen S, Mouridsen K, Wu O etal. Comparison of 10 perfusion MRI parameters in 97 sub-6-hour stroke patients using voxel-based receiver operating characteristics analysis. Stroke 2009; 40:2055-2061.
37. Zaro-Weber O, Moeller-Hartmann W, Heiss WD, Sobesky J. Maps of time to maximum and time to peak for mismatch definition in clinical stroke studies validated with positron emission tomography. Stroke 2010; 41:2817-2821.
38. Nagakane Y, Christensen S, Ogata T etal. Moving beyond a single perfusion threshold to define penumbra: a novel probabilistic mismatch definition. Stroke 2012; 43:1548-1555.
39. Olivot JM, Mlynash M, Zaharchuk G etal. Perfusion MRI (Tmax and MTT) correlation with xenon CT cerebral blood flow in stroke patients. Neurology 2009; 72:1140-1145.
40. Christensen S, Campbell BCV, Perez de la Ossa N etal. Optimal perfusion thresholds for prediction of tissue destined for infarction in the combined EPITHET and DEFUSE dataset. Stroke 2010; 41:e297.
41. Olivot JM, Mlynash M, Thijs VN etal. Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke 2009; 40:469-475.
42. Campbell BCV, Christensen S, Tress BM etal. Failure of collateral blood flow is associated with infarct growth in ischemic stroke. J. Cereb Blood Flow and Metab 2013; 33:1168-1172.
43. Christensen S, Parsons MW, De Silva DA etal. Optimal mismatch definitions for detecting treatment response in acute stroke. Cerebrovasc Dis 2008; 25(Suppl. 2):33.
44. Kakuda W, Lansberg MG, Thijs VN etal. Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients. J Cereb Blood Flow Metab 2008; 28:887-891.
45. Warach S, Al-Rawi Y, Furlan AJ etal. Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection: insights from the desmoteplase in acute stroke trials. Stroke 2012; 43:2313-2318.
46. Kidwell CS, Wintermark M, De Silva DA etal. Multiparametric MRI and CT models of infarct core and favorable penumbral imaging patterns in acute ischemic stroke. Stroke 2013; 44:73-79.
47. Kidwell CS, Jahan R, Gornbein J etal. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013; 368:914-923.
48. Parsons MW, Albers GW. MR RESCUE: is the glass half-full or half-empty? Stroke 2013; 44:2055-2057.
49. Campbell BCV, Christensen S, Parsons MW etal. Advanced imaging improves prediction of hemorrhage after stroke thrombolysis. Ann Neurol 2013; 73:510-519.
50. Campbell BCV, Christensen S, Butcher KS etal. Regional very low cerebral blood volume predicts hemorrhagic transformation better than diffusion-weighted imaging volume and thresholded apparent diffusion coefficient in acute ischemic stroke. Stroke 2010; 41:82-88.
51. Kim JH, Bang OY, Liebeskind DS etal. Impact of baseline tissue status (diffusion-weighted imaging lesion) versus perfusion status (severity of hypoperfusion) on hemorrhagic transformation. Stroke 2010; 41:e135-142.
52. Mlynash M, Lansberg MG, De Silva DA etal. Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set. Stroke 2011; 42:1270-1275.
53. Planas AM. Noninvasive brain imaging in small animal stroke models: MRI and PET; in Dirnagl U (ed.): Rodent Models of Stroke. Springer Protocols Neuromethods 47. New York, Humana Press, 2010:139-165.
54. Traystman RJ. Effect of anaesthesia in stroke models; in Dirnagl U (ed.): Rodent Models of Stroke. Springer Protocols Neuromethods 47. New York, Humana Press, 2010:121-138.
55. Bulloch R, McCulloch J, Graham DI, Lowe D, Chen MH, Teasdale GM. Focal ischemia in the cat: pre-treatment with a competitive NMDA receptor antagonist, D-CPP-ene. J Cereb Blood Flow Metab 1990; 10:668-674.
56. Imai H, Konno K, Nakamura M etal. A new model of focal cerebral ischaemia in the miniature pig. J Neurosurg 2006; 104:123-132.
57. Yonas H, Wolfson SK, Dujovny M, Boehnke M, Cook E. Selective lenticulostriate occlusion in the primate. A highly focal cerebral ischemia model. Stroke 1981; 12:567-572.
58. Hesselbarth D, Franke C, Hata R, Brinker G, Hoehn-Berlage M. High resolution MRI and MRS: a feasibility study for the investigation of focal cerebral ischemia in mice. NMR Biomed 1998; 11:423-429.
59. Paul R, Zhang ZG, Eliceiri BP etal. Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat Med 2001; 7:222-227.
60. Hughes PM, Allegrini PR, Rudin M, Perry VH, Mir AK, Wiessner C. Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J Cereb Blood Flow Metab 2002; 22:308-317.
61. Anderson SA, Frank JA. MRI of mouse models of neurological disorders. NMR Biomed 2007; 20:200-215.
62. Hoehn-Berlage M, Hossmann KA, Busch E, Eis M, Schmitz B, Gyngell ML. Inhibition of nonselective cation channels reduces focal ischemic injury of rat brain. J Cereb Blood Flow Metab 1997; 17:534-542.
63. Li F, Han S, Tatlisumak T etal. A new method to improve in-bore middle cerebral artery occlusion in rats: demonstration with diffusion- and perfusion-weighted imaging. Stroke 1998; 29:1715-1720.
64. Hoehn-Berlage M, Norris DG, Kohno K, Mies G, Leibfritz D, Hossmann K-A. Evolution of regional changes in apparent diffusion coefficient during focal ischemia of rat brain: the relationship of quantitative diffusion NMR imaging to reduction in cerebral blood flow and metabolic disturbance. J Cereb Blood Flow Metab 1995; 5:1002-1011.
65. Lo EH, Pierce AR, Mandeville JB, Rosen BR. Neuroprotection with NBQX in rat focal cerebral ischemia. Effects on ADC probability distribution functions and diffusion-perfusion relationships. Stroke 1997; 28:439-447.
66. Li F, Carano RAD, Irie K, Sotak CH, Fisher M. Temporal evolution of average apparent diffusion coefficient threshold to define ischemic abnormalities in a rat permanent occlusion model. J Stroke Cerebrovasc Dis 2000; 9:1-7.
67. Shen Q, Meng X, Fisher M, Sotak CH, Duong TQ. Pixel-by-pixel spatiotemporal progression of focal ischemia derived using quantitative perfusion and diffusion imaging. J Cereb Blood Flow Metab 2003; 23:1479-1488.
68. Meng X, Fisher M, Shen Q, Sotak CH, Duong TQ. Characterizing the diffusion/perfusion mismatch in experimental focal cerebral ischemia. Ann Neurol 2004; 55:207-212.
69. Reid E, Graham D, Lopez-Gonzalez MR, Holmes WM, Macrae IM, McCabe C. Penumbra detection using PWI/DWI mismatch MRI in a rat stroke model with and without co-morbidity: comparison of methods. J Cereb Blood Flow Metab 2012; 32:1765-1777.
70. Foley LM, Hitchens TK, Barbe B etal. Quantitative temporal profiles of penumbra and infarction during permanent middle cerebral artery occlusion in rats. Transl Stroke Res 2010; 1:220-229.
71. Letourneur A, Roussel S, Toutain J, Bernaudin M, Touzani O. Impact of genetic and renovascular chronic arterial hypertension on the acute spatiotemporal evolution of the ischemic penumbra: a sequential study with MRI in the rat. J Cereb Blood Flow Metab 2011; 31:504-513.
72. Bardutzky J, Shen Q, Henninger N, Bouley J, Duong TQ, Fisher M. Differences in ischemic lesion evolution in different rat strains using diffusion and perfusion imaging. Stroke 2005; 36:2000-2005.
73. 14C]2-deoxyglucose autoradiography. J Cereb Blood Flow Metab 2011; 31:1778-1787.
74. Robertson C, McCabe C, Gallagher L etal. Stroke penumbra defined by an MRI-based oxygen challenge technique: 2. Validation based on the consequences of reperfusion. J Cereb Blood Flow Metab 2011; 31:1788-1798.
75. Bråtane BT, Bouley J, Schneider A, Bastan B, Henninger N, Fisher M. Granulocyte-colony stimulating factor delays PWI/DWI mismatch evolution and reduces final infarct volume in permanent-suture and embolic focal cerebral ischemia models in the rat. Stroke 2009; 40:3102-3106.
76. Bråtane BT, Cui H, Cook DJ, Bouley J, Tymianski M, Fisher M. Neuroprotection by freezing ischemic penumbra evolution without cerebral blood flow augmentation with a postsynaptic density-95 protein inhibitor. Stroke 2011; 42:3265-3270.
77. McCabe C, Gallagher L, Gsell W, Graham D, Dominiczak AF, Macrae IM. Differences in the evolution of the ischaemic penumbra in the SHRSP and WKY rat. Stroke 2009; 40:3864-3868.